Pomerantz LLP Investigating Nutex Health Securities Fraud Claims
ByAinvest
Sunday, Aug 17, 2025 11:27 am ET1min read
NUTX--
The investigation was triggered by a report published by Blue Orca Capital on July 22, 2025. The report alleged that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor that was recently sued for a "coordinated fraudulent scheme" to take millions from insurance companies on behalf of healthcare billing clients [2]. Following the publication of the report, Nutex's stock price fell by 10.05%, closing at $100.01 per share [2].
Pomerantz LLP encourages investors who have suffered losses to contact Danielle Peyton at 646-581-9980, ext. 7980, to discuss their rights. The firm has a proven track record of recovering multimillion-dollar damages for class members in securities fraud cases [3].
References:
[1] https://www.marketscreener.com/news/nutx-investors-have-opportunity-to-join-nutex-health-inc-fraud-investigation-with-the-schall-law-fi-ce7c51ded181f521
[2] https://www.globenewswire.com/news-release/2025/08/12/3132033/32716/en/Nutex-Health-NUTX-Shares-Fall-Amid-Critical-Blue-Orca-Report-Hagens-Berman.html
[3] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutex-health-inc---nutx-302527399.html
Pomerantz LLP is investigating claims of securities fraud against Nutex Health Inc. (NASDAQ: NUTX) on behalf of investors. The investigation concerns allegations that Nutex and its officers and directors may have engaged in unlawful business practices. The stock price fell 10.05% after a Blue Orca report alleged that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor sued for a "coordinated fraudulent scheme."
Pomerantz LLP, a renowned law firm specializing in corporate and securities litigation, has initiated an investigation into allegations of securities fraud against Nutex Health Inc. (NASDAQ: NUTX) on behalf of its investors. The investigation focuses on whether Nutex and its officers and directors engaged in unlawful business practices [3].The investigation was triggered by a report published by Blue Orca Capital on July 22, 2025. The report alleged that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor that was recently sued for a "coordinated fraudulent scheme" to take millions from insurance companies on behalf of healthcare billing clients [2]. Following the publication of the report, Nutex's stock price fell by 10.05%, closing at $100.01 per share [2].
Pomerantz LLP encourages investors who have suffered losses to contact Danielle Peyton at 646-581-9980, ext. 7980, to discuss their rights. The firm has a proven track record of recovering multimillion-dollar damages for class members in securities fraud cases [3].
References:
[1] https://www.marketscreener.com/news/nutx-investors-have-opportunity-to-join-nutex-health-inc-fraud-investigation-with-the-schall-law-fi-ce7c51ded181f521
[2] https://www.globenewswire.com/news-release/2025/08/12/3132033/32716/en/Nutex-Health-NUTX-Shares-Fall-Amid-Critical-Blue-Orca-Report-Hagens-Berman.html
[3] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutex-health-inc---nutx-302527399.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet